$1.38
0.0554.17%
Last update: Oct 1, 7:54 PM
$1.40
0.086.06%
Lite Strategy Inc (LITS) Stock Price, Quote, News & History
LITSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Lite Strategy (NASDAQ:LITS) through any online brokerage.
Other companies in Lite Strategy’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Lite Strategy to provide a consensus price target.
The stock price for Lite Strategy (NASDAQ: LITS) is $1.4 last updated October 1, 2026 at 7:54 PM EDT.
There are no upcoming dividends for Lite Strategy.
Lite Strategy does not have any upcoming earnings scheduled.
There is no upcoming split for Lite Strategy.
Lite Strategy is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective...
